Publications in collaboration with researchers from David Geffen School of Medicine at UCLA (67)

2024

  1. A novel long non-coding RNA connects obesity to impaired adipocyte function

    Molecular Metabolism, Vol. 90

  2. Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus

    Lupus Science and Medicine, Vol. 11, Núm. 1

  3. OMERACT systemic lupus erythematosus domain survey

    Seminars in Arthritis and Rheumatism, Vol. 68

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  3. Evaluating the Construct of Damage in Systemic Lupus Erythematosus

    Arthritis Care and Research, Vol. 75, Núm. 5, pp. 998-1006

  4. Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 7, pp. 927-936

  5. The 2023 ACR/EULAR Classification Criteria for Calcium Pyrophosphate Deposition Disease

    Arthritis and Rheumatology, Vol. 75, Núm. 10, pp. 1703-1713

  6. The 2023 ACR/EULAR classification criteria for calcium pyrophosphate deposition disease

    Annals of the Rheumatic Diseases, Vol. 82, Núm. 10, pp. 1248-1257

2022

  1. Economic impact of the first pass effect in mechanical thrombectomy for acute ischaemic stroke treatment in Spain: A cost-effectiveness analysis from the national health system perspective

    BMJ Open, Vol. 12, Núm. 9

  2. Flares after hydroxychloroquine reduction or discontinuation: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the rheumatic diseases, Vol. 81, Núm. 3, pp. 370-378

  3. Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction

    Arthritis Care and Research, Vol. 74, Núm. 10, pp. 1649-1658

  4. Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 8, pp. 1143-1150

  5. Prediction of Hospitalizations in Systemic Lupus Erythematosus Using the Systemic Lupus International Collaborating Clinics Frailty Index

    Arthritis Care and Research, Vol. 74, Núm. 4, pp. 638-647

  6. Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort

    Annals of the Rheumatic Diseases, Vol. 81, Núm. 11, pp. 1541-1548

2021

  1. Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications

    Arthritis Care and Research, Vol. 73, Núm. 12, pp. 1789-1795

  2. European League against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

    Annals of the Rheumatic Diseases, Vol. 80, Núm. 6, pp. 775-781

  3. Impact of glucocorticoids on the incidence of lupus-related major organ damage: A systematic literature review and meta-regression analysis of longitudinal observational studies

    Lupus Science and Medicine, Vol. 8, Núm. 1

  4. Lower vitamin D is associated with metabolic syndrome and insulin resistance in systemic lupus: Data from an international inception cohort

    Rheumatology (United Kingdom), Vol. 60, Núm. 10, pp. 4737-4747

  5. Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys

    Value in Health, Vol. 24, Núm. 11, pp. 1676-1685